Its announcement comes around the heels of an analogous licensing arrangement offered in February to Adastra Labs, which had until eventually now focused on crafting cannabis extracts. Adastra's license also allows it to provide and market psilocybin and psilocin – hallucinogens additional commonly often called magic mushrooms that make results m